Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 11, 2013 - Issue 6
Submit an article Journal homepage
96
Views
5
CrossRef citations to date
0
Altmetric
Special Report

H1N1 pandemic: clinical and epidemiologic characteristics of the Canadian pediatric outbreak

Olivier Fléchelles Pediatric ICU, Sainte-Justine Hospital, Montreal, QC, Canada; Pediatric and Neonatal ICU, MFME Hospital, Fort de France, Martinique, France; Pediatric ICU, Sainte-Justine Hospital, Montreal, QC, Canada; Pediatric and Neonatal ICU, MFME Hospital, Fort de France, Martinique, France
,
Robert Fowler Department of Critical Care Medicine, Sunnybrook Hospital University of Toronto, Toronto, ON, Canada; Department of Critical Care Medicine, Sunnybrook Hospital University of Toronto, Toronto, ON, Canada
&
Philippe Jouvet Pediatric ICU, Sainte-Justine Hospital, Montreal, QC, Canada; Research Center, Sainte-Justine Hospital, Montreal, QC, Canada. [email protected]; Research Center, Sainte-Justine Hospital, Montreal, QC, Canada. [email protected]
Pages 555-563 | Published online: 10 Jan 2014

References

  • Helferty M, Vachon J, Tarasuk J, Rodin R, Spika J, Pelletier L. Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009. CMAJ 182(18), 1981–1987 (2010).
  • Dushoff J, Plotkin JB, Viboud C, Earn DJ, Simonsen L. Mortality due to influenza in the United States – an annualized regression approach using multiple-cause mortality data. Am. J. Epidemiol. 163(2), 181–187 (2006).
  • WHO. Epidemiological summary of pandemic influenza A (H1N1) 2009 virus – Ontario, Canada, June 2009. Weekly Epidemiological Record 47, 485–492 (2009).
  • Morris SK, Parkin P, Science M et al. A retrospective cross-sectional study of risk factors and clinical spectrum of children admitted to hospital with pandemic H1N1 influenza as compared to influenza A. BMJ Open 2(2), e000310 (2012).
  • Tran D, Vaudry W, Moore DL et al.; IMPACT investigators. Comparison of children hospitalized with seasonal versus pandemic influenza A, 2004–2009. Pediatrics 130(3), 397–406 (2012).
  • Schanzer D, Vachon J, Pelletier L. Age-specific differences in influenza A epidemic curves: do children drive the spread of influenza epidemics? Am. J. Epidemiol. 174(1), 109–117 (2011).
  • Launay E, Ovetchkine P, Saint-Jean M et al. Novel influenza A (H1N1): clinical features of pediatric hospitalizations in two successive waves. Int. J. Infect. Dis. 15(2), e122–e130 (2011).
  • O’Riordan S, Barton M, Yau Y, Read SE, Allen U, Tran D. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 182(1), 39–44 (2010).
  • Eriksson CO, Graham DA, Uyeki TM, Randolph AG. Risk factors for mechanical ventilation in U.S. children hospitalized with seasonal influenza and 2009 pandemic influenza A*. Pediatr. Crit. Care Med. 13(6), 625–631 (2012).
  • Kotsimbos T, Waterer G, Jenkins C et al.; Thoracic Society of Australia and New Zealand H1N1 Influenza 09 Task Force. Influenza A/H1N1_09: Australia and New Zealand’s winter of discontent. Am. J. Respir. Crit. Care Med. 181(4), 300–306 (2010).
  • Jouvet P, Hutchison J, Pinto R et al.; Canadian Critical Care Trials Group H1N1 Collaborative. Critical illness in children with influenza A/pH1N1 2009 infection in Canada. Pediatr. Crit. Care Med. 11(5), 603–609 (2010).
  • Fléchelles O, Brissaud O, Fowler R, Jouvet P. H1N1 Pandemic: comparison of the clinical presentation between Canada and France in critically ill children. Arc. Dis. Childhood 97(Suppl. 2), A1–A539 (2012).
  • Mosby LG, Rasmussen SA, Jamieson DJ. 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am. J. Obstet. Gynecol. 205(1), 10–18 (2011).
  • Rolland-Harris E, Vachon J, Kropp R et al. Hospitalization of pregnant women with pandemic A(H1N1) 2009 influenza in Canada. Epidemiol. Infect. 140(7), 1316–1327 (2012).
  • Public Health Agency of Canada. Fluwatch report April 25 to May 1 2020. Fluwatch 17, 1–6(2010).
  • Centers for Disease Control and Prevention. Deaths related to 2009 pandemic influenza A (H1N1) among American Indian/Alaska Natives – 12 states, 2009. MMWR Morb. Mortal. Wkly. Rep. 58(48), 1341–1344 (2009).
  • Tricco AC, Lillie E, Soobiah C, Perrier L, Straus SE. Impact of H1N1 on socially disadvantaged populations: systematic review. PLoS ONE 7(6), e39437 (2012).
  • Boggild AK, Yuan L, Low DE, McGeer AJ. The impact of influenza on the Canadian First Nations. Can. J. Public Health. 102(5), 345–348 (2011).
  • Jain R, Goldman RD. Novel influenza A(H1N1): clinical presentation, diagnosis, and management. Pediatr. Emerg. Care 25(11), 791–796 (2009).
  • Jamieson B, Jain R, Carleton B, Goldman RD. Use of oseltamivir in children. Can. Fam. Physician 55(12), 1199–1201 (2009).
  • Zarychanski R, Stuart TL, Kumar A et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 182(3), 257–264 (2010).
  • Wang K, Shun-Shin M, Gill P, Perera R, Harnden A. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). Cochrane Database Syst. Rev. 4, CD002744 (2012).
  • Garg S, Fry AM, Patton M, Fiore AE, Finelli L. Antiviral treatment of influenza in children. Pediatr. Infect. Dis. J. 31(2), e43–e51 (2012).
  • Public Health Agency of Canada. Fluwatch report August 15 to August 29, 2010. Fluwatch 33–34, 1–6 (2010).
  • Mahmud SM, Becker M, Keynan Y et al. Estimated cumulative incidence of pandemic (H1N1) influenza among pregnant women during the first wave of the 2009 pandemic. CMAJ 182(14), 1522–1524 (2010).
  • Achonu C, Rosella L, Gubbay JB et al. Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009–May 2010. PLoS ONE 6(11), e26427 (2011).
  • Tuite AR, Greer AL, Whelan M et al. Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ 182(2), 131–136 (2010).
  • Hsieh YH, Fisman DN, Wu J. On epidemic modeling in real time: an application to the 2009 novel A (H1N1) influenza outbreak in Canada. BMC Res. Notes 3, 283 (2010).
  • Bautista E, Chotpitayasunondh T, Gao Z et al.; Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. New Eng. J. Med. 362(18), 1708–1719 (2010).
  • Mostaço-Guidolin LC, Greer A, Sander B, Wu J, Moghadas SM. Variability in transmissibility of the 2009 H1N1 pandemic in Canadian communities. BMC Res. Notes 4, 537 (2011).
  • Papenburg J, Baz M, Hamelin MÈ et al. Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory-confirmed secondary attack rates and evidence of asymptomatic infections. Clin. Infect. Dis. 51(9), 1033–1041 (2010).
  • Lewin T. Summer camp ‘09: a swin, an cough, a quarantine. The New York Times, 23 July 2009.
  • Eames KT, Tilston NL, Brooks-Pollock E, Edmunds WJ. Measured dynamic social contact patterns explain the spread of H1N1v influenza. PLoS Comput. Biol. 8(3), e1002425 (2012).
  • Hayden FG, Belshe R, Villanueva C et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J. Infect. Dis. 189(3), 440–449 (2004).
  • Pebody RG, Harris R, Kafatos G et al. Use of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United Kingdom. Emerging Infect. Dis. 17(6), 990–999 (2011).
  • Gojovic MZ, Sander B, Fisman D, Krahn MD, Bauch CT. Modelling mitigation strategies for pandemic (H1N1) 2009. CMAJ 181(10), 673–680 (2009).
  • Earn DJ, He D, Loeb MB, Fonseca K, Lee BE, Dushoff J. Effects of school closure on incidence of pandemic influenza in Alberta, Canada. Ann. Intern. Med. 156(3), 173–181 (2012).
  • Miller MA, Viboud C, Olson DR, Grais RF, Rabaa MA, Simonsen L. Prioritization of influenza pandemic vaccination to minimize years of life lost. J. Infect. Dis. 198(3), 305–311 (2008).
  • WHO. Pandemic (H1N1) 2009 Briefing Note 2: WHO Recommendations on Pandemic (H1N1) 2009 Vaccines. WHO, Geneva, Switzerland (2009).
  • Nolan T, McVernon J, Skeljo M et al. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA 303(1), 37–46 (2010).
  • Brien S, Kwong JC, Charland KM, Verma AD, Brownstein JS, Buckeridge DL. Neighborhood determinants of 2009 pandemic A/H1N1 influenza vaccination in Montreal, Quebec, Canada. Am. J. Epidemiol. 176(10), 897–908 (2012).
  • Gilmour H, Hofmann N. H1N1 vaccination. Health Rep. 21(4), 63–69 (2010).
  • Skowronski DM, Hottes TS, Janjua NZ et al. Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ 182(17), 1851–1856 (2010).
  • Tuite AR, Fisman DN, Kwong JC, Greer AL. Optimal pandemic influenza vaccine allocation strategies for the Canadian population. PLoS ONE 5(5), e10520 (2010).
  • Fell DB, Sprague AE, Liu N et al.; Better Outcomes Registry & Network (BORN) Ontario. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am. J. Public Health 102(6), e33–e40 (2012).
  • Conway JM, Tuite AR, Fisman DN et al. Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everything. BMC Public Health 11, 932 (2011).
  • Schuler JE, King WJ, Dayneka NL et al. Administration of the adjuvanted pH1N1 vaccine in egg-allergic children at high risk for influenza A/H1N1 disease. Can. J. Public Health. 102(3), 196–199 (2011).
  • Yin JK, Khandaker G, Rashid H, Heron L, Ridda I, Booy R. Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis. Influenza Other Respi. Viruses 5(5), 299–305 (2011).
  • De Wals P, Deceuninck G, Toth E et al. Risk of Guillain–Barré syndrome following H1N1 influenza vaccination in Quebec. JAMA 308(2), 175–181 (2012).
  • Smetanin P, Stiff D, Kumar A et al. Potential intensive care unit ventilator demand/capacity mismatch due to novel swine-origin H1N1 in Canada. Can. J. Infect. Dis. Med. Microbiol. 20(4), e115–e123 (2009).
  • Stiff D, Kumar A, Kissoon N et al. Potential pediatric intensive care unit demand/capacity mismatch due to novel pH1N1 in Canada. Pediatr. Crit. Care Med. 12(2), e51–e57 (2011).
  • Jouvet P, Greenblatt M, Kissoon N et al. Impact of H1N1 pandemic on quality indicators in Canadian pediatric intensive care units: preliminary data. Intensive Care Med. 37(Suppl. 2), S362–S363 (2011).
  • Ma J, Dushoff J, Earn DJ. Age-specific mortality risk from pandemic influenza. J. Theor. Biol. 288, 29–34 (2011).
  • Burton C, Vaudry W, Moore D et al.; Canadian Immunization Monitoring Program Active (IMPACT). Children hospitalized with influenza during the 2006–2007 season: a report from the Canadian Immunization Monitoring Program, Active (IMPACT). Can. Commun. Dis. Rep. 34(12), 17–32 (2008).
  • Kendirli T, Demirkol D, Yildizdas D et al. Critically ill children with pandemic influenza (H1N1) in pediatric intensive care units in Turkey. Pediatr. Crit. Care Med. 13(1), e11–e17 (2012).
  • Torres SF, Iolster T, Schnitzler EJ et al. High mortality in patients with influenza A pH1N1 2009 admitted to a pediatric intensive care unit: a predictive model of mortality. Pediatr. Crit. Care Med. 13(2), e78–e83 (2012).
  • Randolph AG, Vaughn F, Sullivan R et al.; Pediatric Acute Lung Injury and Sepsis Investigator’s Network and the National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Critically ill children during the 2009–2010 influenza pandemic in the United States. Pediatrics 128(6), e1450–e1458 (2011).
  • Brissaud O, Nolent P, Javouhey E, Renolleau E, Leclerc F. Pandemic 2009 influenza A virus (pH1N1) infection in French PICU. Pediatr. Crit. Care Med. 12(Suppl. 3), A66 (2011).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.